撤回：肝细胞癌肿瘤免疫微环境中介体复合物家族基因中治疗靶点和预后生物标志物的鉴定
Retracted: Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
作者信息
Methods In Medicine Computational And Mathematical
出版信息
Comput Math Methods Med. 2023 Dec 6;2023:9760920. doi: 10.1155/2023/9760920. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2022/2021613.].
摘要
[本文撤回文章DOI: 10.1155/2022/2021613。]
相似文献
1
Retracted: Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
Comput Math Methods Med. 2023 Dec 6;2023:9760920. doi: 10.1155/2023/9760920. eCollection 2023.
2
Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
Comput Math Methods Med. 2022 Jan 13;2022:2021613. doi: 10.1155/2022/2021613. eCollection 2022.
3
Retracted: Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma.
J Healthc Eng. 2023 Oct 11;2023:9764352. doi: 10.1155/2023/9764352. eCollection 2023.
4
Retracted: Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.
Dis Markers. 2023 Jun 21;2023:9893453. doi: 10.1155/2023/9893453. eCollection 2023.
5
Retracted: LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.
Comput Math Methods Med. 2023 Dec 6;2023:9764203. doi: 10.1155/2023/9764203. eCollection 2023.
6
Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
Evid Based Complement Alternat Med. 2023 Sep 27;2023:9819147. doi: 10.1155/2023/9819147. eCollection 2023.
7
Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma.
Dis Markers. 2023 Jul 26;2023:9809678. doi: 10.1155/2023/9809678. eCollection 2023.
8
Retracted: G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Dis Markers. 2023 Jul 19;2023:9806936. doi: 10.1155/2023/9806936. eCollection 2023.
9
Retracted: Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma.
Evid Based Complement Alternat Med. 2023 Jun 21;2023:9761231. doi: 10.1155/2023/9761231. eCollection 2023.
10
Retracted: Development and Optimization of a Prognostic Model Associated with Stemness Genes in Hepatocellular Carcinoma.
Biomed Res Int. 2024 Jan 9;2024:9815950. doi: 10.1155/2024/9815950. eCollection 2024.
本文引用的文献
1
Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
Comput Math Methods Med. 2022 Jan 13;2022:2021613. doi: 10.1155/2022/2021613. eCollection 2022.
Zotero 插件